User profiles for Lloyd B. Mulenga
lloyd mulengaMinistry of Health, University Teaching Hospital, University of Zambia, Vanderbilt University Verified email at moh.gov.zm Cited by 2919 |
[HTML][HTML] Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
LB Mulenga, JZ Hines, S Fwoloshi, L Chirwa… - The Lancet Global …, 2021 - thelancet.com
Background Between March and December, 2020, more than 20 000 laboratory-confirmed
cases of SARS-CoV-2 infection were reported in Zambia. However, the number of SARS-CoV…
cases of SARS-CoV-2 infection were reported in Zambia. However, the number of SARS-CoV…
Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia
LB Mulenga, G Kruse, S Lakhi, RA Cantrell, SE Reid… - Aids, 2008 - journals.lww.com
Objective: To examine the association between baseline renal insufficiency and mortality
among adults initiating antiretroviral therapy (ART) in an urban African setting. Design: Open …
among adults initiating antiretroviral therapy (ART) in an urban African setting. Design: Open …
[HTML][HTML] Metabolic syndrome in Zambian adults with human immunodeficiency virus on antiretroviral therapy: prevalence and associated factors
Metabolic syndrome (MetS) is a constellation of factors including hypertension, abdominal
obesity, dyslipidemia, and insulin resistance that separately and together significantly …
obesity, dyslipidemia, and insulin resistance that separately and together significantly …
Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia
BH Chi, RA Cantrell, I Zulu, LB Mulenga… - International journal …, 2009 - academic.oup.com
Background High-level adherence to antiretroviral therapy (ART) is associated with favourable
patient outcomes. In resource-constrained settings, however, there are few validated …
patient outcomes. In resource-constrained settings, however, there are few validated …
Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy
JD Goldman, RA Cantrell, LB Mulenga… - AIDS research and …, 2008 - liebertpub.com
We evaluated the association between two antiretroviral therapy (ART) adherence
measurements—the medication possession ratio (MPR) and patient self-report—and detectable HIV …
measurements—the medication possession ratio (MPR) and patient self-report—and detectable HIV …
[HTML][HTML] Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage …
…, DV Glidden, E Chizema, LB Mulenga… - PLoS …, 2019 - journals.plos.org
Background Although the success of HIV treatment programs depends on retention and viral
suppression, routine program monitoring of these outcomes may be incomplete. We used …
suppression, routine program monitoring of these outcomes may be incomplete. We used …
Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID‐19
…, C Katureebe, S Agolory, LB Mulenga… - Journal of the …, 2022 - Wiley Online Library
Introduction The potential disruption in antiretroviral therapy (ART) services in Africa at the
start of the COVID‐19 pandemic raised concern for increased morbidity and mortality among …
start of the COVID‐19 pandemic raised concern for increased morbidity and mortality among …
Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia
Background. We investigated changes in hepatic fibrosis, based on transient elastography (TE),
among human immunodeficiency virus (HIV)–infected patients with and without hepatitis …
among human immunodeficiency virus (HIV)–infected patients with and without hepatitis …
Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia
…, LB Mulenga, B Tambatamba-Chapula… - JAIDS Journal of …, 2010 - journals.lww.com
Background: In July 2007, amid some controversy over cost, Zambia was the first African
country to introduce tenofovir (TDF) as a component of first-line antiretroviral therapy (ART) on a …
country to introduce tenofovir (TDF) as a component of first-line antiretroviral therapy (ART) on a …
An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs
…, W Mutale, M Limbada, LB Mulenga… - American journal of …, 2010 - academic.oup.com
In many programs providing antiretroviral therapy (ART), clinicians report substantial patient
attrition; however, there are no consensus criteria for defining patient loss to follow-up (LTFU…
attrition; however, there are no consensus criteria for defining patient loss to follow-up (LTFU…